Cited by 839Ubiquitin and proteasome pathwaysEnzyme Structure and FunctionProtein Kinase Regulation and GTPase Signaling

Structure of a c-Cbl–UbcH7 Complex

Open access
Zheng, Ning, Wang, Ping, Jeffrey, Philip D., Pavletich, Nikola P.·2000·Cell

Abstract

Ubiquitin-protein ligases (E3s) regulate diverse cellular processes by mediating protein ubiquitination. The c-Cbl proto-oncogene is a RING family E3 that recognizes activated receptor tyrosine kinases, promotes their ubiquitination by a ubiquitin-conjugating enzyme (E2) and terminates signaling. The crystal structure of c-Cbl bound to a cognate E2 and a kinase peptide shows how the RING domain recruits the E2. A comparison with a HECT family E3-E2 complex indicates that a common E2 motif is recognized by the two E3 families. The structure reveals a rigid coupling between the peptide binding and the E2 binding domains and a conserved surface channel leading from the peptide to the E2 active site, suggesting that RING E3s may function as scaffolds that position the substrate and the E2 optimally for ubiquitin transfer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0092-8674(00)00057-x

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • None of the generated RING mutations, including V389A and V420A, resulted in marked changes in degradation of the LDLR or VLDLR.

    “None of the mutations we generated, including V389A and V420A that correspond to the detrimental Ile-383 and Phe-418 in c-Cbl (17), resulted in marked changes in degradation of the LDLR (Fig. 2B) or VLDLR (Fig. 2C).”

    From Distinct Functional Domains Contribute to Degradation of the Low Density Lipoprotein Receptor (LDLR) by the E3 Ubiquitin Ligase Inducible Degrader of the LDLR (IDOL) (2011) · cites this paper as [17]

    The c-Cbl–UbcH7 interface passage (section labeled Abstract; page unavailable) identifies Ile-383 and Phe-418 as residues that contact UbcH7, supporting the cited comparison of RING residues. Our copy does not show that mutations of those two c-Cbl residues are detrimental. The LDLR and VLDLR degradation results are the citing authors’ own findings, not findings attributed to this source. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 4

  1. [1]1. Andoniou, C.E. ∙ Thien, C.B. ∙ Langdon, W.Y. Tumor induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene EMBO J. 1994; 13:4515-4523 Crossref Scopus (221) PubMed Google Scholar
  2. [2]2. Bellon, S.F. ∙ Rodgers, K.K. ∙ Schatz, D.G. ... Crystal structure of the RAG1 dimerization domain reveals multiple zinc-binding motifs including a novel zinc binuclear cluster Nat. Struct. Biol. 1997; 4:586-591 Crossref Scopus (131) PubMed Google Scholar
  3. [3]3. Blake, T.J. ∙ Shapiro, M. ∙ Morse, H.C. ... The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif Oncogene. 1991; 6:653-657 PubMed Google Scholar
  4. [6]6. Cook, W.J. ∙ Jeffrey, L.C. ∙ Sullivan, M.L. ... Three-dimensional structure of a ubiquitin-conjugating enzyme (E2) J. Biol. Chem. 1992; 267:15116-15121

Cited by

Sorted by citations

Authors
Zheng, N., Wang, P., Jeffrey, P. D., & Pavletich, N. P.
Affiliations
Memorial Sloan Kettering Cancer Center (US)
Corresponding author
Pavletich, Nikola P.
Venue
Cell
Publisher
Elsevier BV
Published
2000-08
Volume
102
Issue
4
Pages
533-539
ISSN
0092-8674 (ISSN-L)
OpenAlex
W2015291446
Cited by
839
References
0
Citations by year
2026: 12 · 2025: 15 · 2024: 9 · 2023: 13 · 2022: 14 · 2021: 17 · 2020: 16 · 2019: 14 · 2018: 13 · 2017: 24 · 2016: 22 · 2015: 27 · 2014: 20 · 2013: 46 · 2012: 38
FWCI
18.92
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Physical Sciences › Materials Science › Materials Chemistry › Enzyme Structure and Function
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Keywords
c-Cbl, UbcH7, E3 ubiquitin ligase, RING domain, E2 ubiquitin-conjugating enzyme, ubiquitin-protein ligase, ubiquitination, crystal structure
MeSH terms
Proto-Oncogene Mas, Amino Acid Sequence, Animals, Drosophila, Humans, Ligases, Models, Molecular, Molecular Conformation, Molecular Sequence Data, Protein Conformation, Proto-Oncogene Proteins, Structure-Activity Relationship, Caenorhabditis elegans, Ubiquitin-Conjugating Enzymes, Ubiquitin-Protein Ligases, Macromolecular Substances, Proto-Oncogene Proteins c-cbl

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review